Navigation Links
Hormone Drugs Might Not Raise Heart-Related Deaths in Prostate Patients
Date:12/6/2011

y is published in the Dec. 7 issue of the Journal of the American Medical Association.

Nguyen's team performed a meta-analysis, which attempts to uncover trends from a group of studies to determine a pattern that the original trials may not have actually been designed to find.

Over a range of seven to 13 years of follow-up, 255 of the 2,200 men receiving hormone therapy died from a cardiovascular condition, compared with 252 of the 1,941 men not on hormone therapy, the researchers found. For men on hormone therapy that's an overall incidence of 11 percent, compared with 11.2 percent for men not on hormone therapy, the study authors noted.

For men who took hormones for six months, the overall incidence of cardiovascular death was 10.5 percent, compared with 10.3 percent for men not on hormone therapy. For those who took hormones for three years or more, the incidence of cardiovascular death was 11.5 percent, the same as for men not receiving hormone therapy, the investigators found.

Age seemed to play no role in these findings, Nguyen's group said.

Among men receiving hormone therapy, 443 died from prostate cancer as did 522 of the men not receiving hormone therapy.

Of the more than 1,100 deaths of men receiving hormone therapy and more than 1,200 deaths of men not receiving hormone therapy, those on hormone therapy had a 14 percent lower risk of dying from any cause, the researchers found.

"The use of hormone therapy and radiation is of benefit for patients," said Dr. William Kelly, a professor of medical oncology and urology at Thomas Jefferson University's Kimmel Cancer Center in Philadelphia and co-author of an accompanying journal editorial.

In this study, the benefits of hormone therapy outweighed the risks, Kelly said. However, he noted that these were selected patients in clinical trials, not patients in the general population, in which sicker patients might be at risk for cardiovascular events from
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. When babies awake: New study shows surprise regarding important hormone level
2. Combo hormone therapy has increased breast cancer risk over estrogen alone
3. Hormone that controls iron levels may be target for atherosclerosis treatment
4. Radiation Plus Hormone Therapy Extends Life in High-Risk Prostate Cancer
5. Radiation plus hormone therapy greatly improves survival
6. Hormone in birth control shot linked to memory loss
7. Obese people regain weight after dieting due to hormones
8. Hunger Hormones May Drive Post-Dieting Weight Gain
9. Research involving thyroid hormone lays foundation for more targeted drug development
10. Breast Cancer Risk May Rise With High Hormone Levels
11. Elevated hormone levels add up to increased breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Drugs Might Not Raise Heart-Related Deaths in Prostate Patients
(Date:4/14/2014)... centers around the world, many people live and work ... that block sunlight. And as the global population continues ... darkness will only spread. , To alleviate the ... that redirects sunlight onto narrow streets and alleyways. The ... edge at an angle, where it spreads sunlight onto ...
(Date:4/14/2014)... associate professor of chemical engineering at Virginia Tech ... efficiently analyze living cells. The long-term goal is to ... , In his lab , Lu and his ... molecular events inside cells. These devices promote high sensitivity ... of cells. , Based on their record of achievements, ...
(Date:4/14/2014)... April 2014, Perth, Australia. Drug discovery company Proteomics ... development of a companion diagnostic (CDx) test with ... , The research team authenticated the panel of ... control samples. Seven biomarkers were validated at high ... , The mass spectrometry data was then cross-validated ...
(Date:4/14/2014)... guidelines for high-risk bladder cancer, chemotherapy before or ... clinical practice. The findings are published early online ... the American Cancer Society. , Clinical trials have ... muscle-invasive bladder cancer who are given chemotherapy before ... after surgery also improves survival. To investigate the ...
(Date:4/11/2014)... insights into the processes that control brain cell production ... and other brain-related disorders. , Scientists have gained new ... that controls how and when nerve and brain cells ... to develop and keeps it healthy. Their findings could ... of control, which is a fundamental characteristic of many ...
Breaking Medicine News(10 mins):Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
... Some patients with large tumors on their larynx can ... surgery to remove the voice box. A new study ... a single round of chemotherapy could identify those patients most ... have excluded these patients because their tumors are so large. ...
... DC (June 25, 2009) Evidence suggests that outcomes in ... means that research into quality improvement (QI) in clinical care ... Now a study in the journal Medical Care Research ... and practical improvements in QI effectiveness studies could make these ...
... FUNCTIONING TISSUE VIOLATES MEDICAL ETHICS, HUMAN RIGHTS OF BABY BOYS ... NEW YORK, June 25 Parents, pediatricians and health and ... and its website -- www.intactamerica.org -- ... campaign argues that painful and medically unnecessary surgery to remove ...
... in German . , Providing reliable ... and labor-intensive molecular-biological procedures. Established methods are particularly hard ... very low, for example during a phase of therapy. ... micro-pumps without movable parts, scientists from the Fraunhofer Institute ...
... June 25 The YWCA USA and many of its 300 ... for Disease Control and Prevention in marking National HIV Testing Day ... to raise public awareness about the fact that one in five ... as a consequence, can unknowingly spread the deadly virus to others. ...
... June 25 The Infectious Disease Research ... M.J. Murdock Charitable Trust. This new funding will support IDRI,s efforts ... identify new drugs to treat it. , ... the air and can be hard to avoid. A seemingly insignificant ...
Cached Medicine News:Health News:U-M study finds voice box can be preserved, even with the largest cancers 2Health News:Health care outcome boost needs better studies 2Health News:Health care outcome boost needs better studies 3Health News:Health care outcome boost needs better studies 4Health News:Intact America Launches Campaign to Change How America Thinks About Male Circumcision 2Health News:Intact America Launches Campaign to Change How America Thinks About Male Circumcision 3Health News:Intact America Launches Campaign to Change How America Thinks About Male Circumcision 4Health News:Virus filters for medical diagnosis 2Health News:YWCAs to Mark National HIV Testing Day on June 27 2Health News:IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program 2Health News:IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program 3
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") ... it has received commitments from institutional investors to ... the Company,s common stock in an at-the-market registered ... fund. The Company entered into definitive ... the Company agreed to sell an aggregate of ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... Trading (OFT) approval condition to the announced tender offer for ...   As a result of the waiver, the ... expects to complete the tender offer on January 24, 2014 ... of all of the remaining conditions to the tender offer. ...
(Date:1/15/2014)... 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ... Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... , RIDGEFIELD, Conn., Aug. 25 Results of ... Warfarin, Compared to Dabigatran)(1) study will be presented at the ... Aug. 30. The primary objective of RE-LY was to ... thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, ...
... August 25 20% of parents seek medical,help because ... baby,and the accompanying discomfort (crying). Reputed medical journal "Archives,of ... recently,published the results of the clinical research project that ... department of the Brussels,University Hospital. , ...
Cached Medicine Technology:Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 2Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 3Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 4Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 5Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 6Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 7Medical World Recognises New Therapy for Reflux Babies 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: